Therapeutic utility of immunosuppressive TREM2+ macrophages: an important step forward in potentiating the immune checkpoint inhibitors

Fulya Koksalar Alkan; Hasan Korkaya

doi:10.1038/s41392-020-00383-5

Therapeutic utility of immunosuppressive TREM2+ macrophages: an important step forward in potentiating the immune checkpoint inhibitors

Fulya Koksalar Alkan, Hasan Korkaya

Biochemistry and Molecular Biology

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Article number	264
Journal	Signal Transduction and Targeted Therapy
Volume	5
Issue number	1
DOIs	https://doi.org/10.1038/s41392-020-00383-5
State	Published - Dec 2020

ASJC Scopus subject areas

Genetics
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41392-020-00383-5

Cite this

@article{0b9858417b2946799f18bac269e0577a,

title = "Therapeutic utility of immunosuppressive TREM2+ macrophages: an important step forward in potentiating the immune checkpoint inhibitors",

author = "Alkan, {Fulya Koksalar} and Hasan Korkaya",

note = "Funding Information: Funding provided to HK by Georgia Cancer Center startup fund, American Cancer Society Intitutional pilot research fund, Bridge Fund by Augusta University Research Inc., Evans County CARES fund and Forbes Institute fund.",

year = "2020",

month = dec,

doi = "10.1038/s41392-020-00383-5",

language = "English (US)",

volume = "5",

journal = "Signal Transduction and Targeted Therapy",

issn = "2095-9907",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Therapeutic utility of immunosuppressive TREM2+ macrophages

T2 - an important step forward in potentiating the immune checkpoint inhibitors

AU - Alkan, Fulya Koksalar

AU - Korkaya, Hasan

N1 - Funding Information: Funding provided to HK by Georgia Cancer Center startup fund, American Cancer Society Intitutional pilot research fund, Bridge Fund by Augusta University Research Inc., Evans County CARES fund and Forbes Institute fund.

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85095818083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095818083&partnerID=8YFLogxK

U2 - 10.1038/s41392-020-00383-5

DO - 10.1038/s41392-020-00383-5

M3 - Article

C2 - 33173037

AN - SCOPUS:85095818083

SN - 2095-9907

VL - 5

JO - Signal Transduction and Targeted Therapy

JF - Signal Transduction and Targeted Therapy

IS - 1

M1 - 264

ER -

Therapeutic utility of immunosuppressive TREM2+ macrophages: an important step forward in potentiating the immune checkpoint inhibitors

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this